ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight

  • 📰 CNBC
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

CAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.

Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world's biggest cancer research conference in Chicago, starting Thursday. Investors have already caught a glimpse of the topics that will be discussed but many are eager to hear the details behind the abstracts, and no doubt there will be surprises. The immunotherapy known as CAR-T, for chimeric antigen receptor T-cell therapy, will be in focus, as it has been in recent years.

mountain News of the trial sparked a surge in Immunogen's shares in early May. In a research note dated May 11, Canaccord Genuity analyst John Newman said that Elahere sales could exceed the current consensus of $154 million this year, offering "potential upside to the current share price." "Cancer is one of the biggest unmet medical needs in the world," Acker said, explaining that 40% of people will be diagnosed with some form of cancer at some point in their lifetimes.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 12. in BR

Brasil Últimas Notícias, Brasil Manchetes